ATPW
ADMA icon

Ashton Thomas Private Wealth’s ADMA Biologics ADMA Stock Holding History

Ashton Thomas Private Wealth’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,463
Closed -$209K – 1505
2025
Q4 		$209K Buy
+11,463
New +$193K 0.01% 951
2025
Q2 		– Sell
-10,924
Closed -$217K – 825
2025
Q1 		$217K Buy
+10,924
New +$189K 0.01% 754
2024
Q4 		– Sell
-17,034
Closed -$341K – 763
2024
Q3 		$341K Sell
17,034
-5,458
-24% -$84.9K 0.02% 493
2024
Q2 		$251K Buy
22,492
+608
+3% +$5.1K 0.01% 520
2024
Q1 		$144K Buy
+21,884
New +$120K 0.01% 588

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Ashton Thomas Private Wealth's ADMA Position: Q1 2026 in Review

Ashton Thomas Private Wealth sold out of ADMA Biologics (ADMA) in Q1 2026, closing a stake of 11,463 shares — an estimated $209K sold.

Ashton Thomas Private Wealth first reported a position in ADMA in Q1 2024 and held it in 5 quarters. The position peaked at $341K in Q3 2024. 357 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Ashton Thomas Private Wealth reported no remaining ADMA Biologics position as of Q1 2026 after selling out during the quarter.
  • Ashton Thomas Private Wealth sold 11,463 ADMA Biologics shares in Q1 2026, an estimated $209K.
  • Ashton Thomas Private Wealth first reported a position in ADMA Biologics in Q1 2024 and held it in 5 quarters.
  • Ashton Thomas Private Wealth's ADMA Biologics position peaked at $341K in Q3 2024.
  • 357 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q1 2026, filed 11 May 2026.